Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2118 participants.
Also called NCT01321255
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 2,118 participants
- Sponsor
- Registry
-
NCT01321255 -
2010-022492-54
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Argentina, Brazil, Italy, Paraguay, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01321255. Randomized; no masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
- Acronym
- FOCUS
- Condition
- Myocardial Infarction
- Intervention (Drug)
- FDC
- Intervention (Drug)
- Separately drugs, simvastatin, aspirin and ramipril
- Lead sponsor
- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Collaborator
- Mario Negri Institute for Pharmacological Research
- Collaborator
- Rusculleda Foundation Instituto DAMIC
- Collaborator
- Fundacion Clinic per a la Recerca Biomédica
- Collaborator
- ARTTIC International Management Services
- Collaborator
- Federación Argentina de Cardiología FAC
- Collaborator
- World Health Organization
- Collaborator
- Instituto de Salud Carlos III
- Collaborator
- Ferrer Internacional S.A.
Record details
- Record id
cardio:ct-nct01321255- Content hash
67c9d6094806a41aad279784568ce2926511bb8c328efc2b12b4129b634e2269